<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Harold Road Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Harold Road Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0208020N0&amp;denomIds=2.8.2&amp;selectedTab=summary">Phenindione</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Oral anticoagulants</td>
      <td>2741</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>17.74</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0208020N0AAAAAA&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Phenindione 10mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0208020N0AAABAB&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Phenindione 25mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301011Z0&amp;denomIds=3.1.1&amp;selectedTab=summary">Olodaterol</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>17</td>
      <td>Selective beta(2)-agonists</td>
      <td>2157</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>13.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301011Z0BBAAAA&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Striverdi Respimat 2.5microg/dose inhalation soln : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301011Z0BBABAB&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Striverdi Respimat 2.5microg/dose inhalation soln refill : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0&amp;denomIds=2.5.5&amp;selectedTab=summary">Telmisartan</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>610</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>2865</td>
      <td>0.21</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>8.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Telmisartan 40mg tablets : 251</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Telmisartan 80mg tablets : 248</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0AAACAC&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Telmisartan 20mg tablets : 92</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0BBAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Micardis 40mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205052Q0BBABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Micardis 80mg tablets : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020M0&amp;denomIds=2.6.2&amp;selectedTab=summary">Nimodipine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Calcium-channel blockers</td>
      <td>5327</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020M0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Nimodipine 30mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020K0&amp;denomIds=2.6.2&amp;selectedTab=summary">Lacidipine</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1149</td>
      <td>Calcium-channel blockers</td>
      <td>5327</td>
      <td>0.22</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>7.46</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020K0AAAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Lacidipine 2mg tablets : 665</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020K0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Lacidipine 4mg tablets : 482</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0206020K0AAAEAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Lacidipine 6mg tablets : 2</a></div></td></tr></tbody></table>

        <h2>Prescribing where Harold Road Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0205010J0&amp;denomIds=2.5.1&amp;selectedTab=summary">Hydralazine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Vasodilator antihypertensive drugs</td>
      <td>5</td>
      <td>0.00</td>
      <td>0.85</td>
      <td>0.28</td>
      <td>-3.01</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0&amp;denomIds=6.1.2&amp;selectedTab=summary">Gliclazide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>237</td>
      <td>Sulfonylureas</td>
      <td>428</td>
      <td>0.55</td>
      <td>0.92</td>
      <td>0.14</td>
      <td>-2.74</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0AAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 80mg tablets : 125</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0AAARAR&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 40mg tablets : 81</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0AAAMAM&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 30mg modified-release tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0AAAVAV&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 160mg tablets : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0601021M0AAATAT&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 60mg modified-release tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0&amp;denomIds=3.2&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>677</td>
      <td>Corticosteroids (respiratory)</td>
      <td>2600</td>
      <td>0.26</td>
      <td>0.57</td>
      <td>0.12</td>
      <td>-2.60</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIEUlEQVR4nO2df+xWVR3HX/cLokiiiwqwpAtYaVqrDBkWjCwdeB1rrubWWj9kuCy1spRLBYNo86JF/toiyx/Dfm5alhwLCQtT99VSt2xqiHQxl6CJUk0CidMfn8OCp+e7+PE899znue/XdnbH9w8+n+f7fF/3nHvO55ybeO8RQjSDgdgJCCGqQ8IL0SAkvBANQsIL0SAkvBANQsIL0SAkvBANQsIL0SAkvBANQsIL0SC6L3ySqHZXiJowPHYC4uBIc3cYMAWYCkwCJgJHAyOBEfv53+wGXgltZ7i+DGwJbSPwJ+Cxsshe6mT+Ig5J1zfPJInH+6S7QZpBmrvhwGzgE8A04BHgPmAD8GfgRWA7Jm/rF9vuOxiG3fRHAIeFNgoYC4wDJgNvAU4GdgD3A6uB1WWR/aNzn0xUhYTvAdLcjQI+HdrvgRuAtWWRvVJhDmOB9wAZcCbwMPBd4Bdlke2qKg9xaEj4GrOX6J8BbgOuLItsc9ysIM3dMOD9wDzgFGAF8C31+vVHwteQuorejjR344HPA+cCNwHXlEW2NW5WYigkfI0Iol8AXEjNRW8lzd0Y4GLgk8CPgOW9knuTkPA1oJdFbyXN3Wjss1wAOOCKssg2xc1K7EHCR6RF9J9gcvSk6K2kuRsJnIcN9+8FirLInoiblZDwEQiifwq4iD4TvZVQL/AR4DJs+fBq4NdlkakgKwISvkJaRP8pJvqzcbOqhjR3A8As4LPYGv/VwA/KIvtX1MQahoSvgCaL3o40dydhE3yzgJXYkt5f42bVDCR8FwnD2XnApcDtNFz0VsLM/rzQ7gO+VhbZ+rhZ9TcSvguE4eu5wGLgt8CSssj+EjWpGrPXc/6XgEFgaVlkG+Jm1Z9I+A6S5i7Byk4vx2rbv1IW2eNxs+odgvgfBRZgPf7Sssg2xs2qv5DwHSLN3VSgCP/MyyJ7IGY+vUwQ/+NAjm3WWdqvqxhVI+EPkTR37wYWAW/Aeqa7tOTUGdLcHYFNdn4O+D5WkKRtuoeAhD9IQo++CFti+ipwR1lku+Nm1Z+E6r1LsLLd64DryiLbHjer3kTCHyBp7k7DRH81JrpTj14Nae5eh03szcHmSW6ucotwPyDh95M0d9Mx0Y8ClgC/lOhxSHOXYisg04BlwC0Sf/+Q8P+HNHczMdEPx0RfI9HrQZq744EvYwdzXAGsLItsZ9ys6o2EH4I0dzMwwYdjvcndEr2epLmbjIk/HbgSG+pL/DZI+BbCM/oS7Gy3hUj0niHN3STsGX8mJv5NEn9fJHwgzLovxibjFqHltZ4lzd1ETPz3Ad8AbiyLbEfcrOpB44VPc3cqJvprw/VOid4fhMm9BcAHgOXADU3fnddY4dPcTcEEHxuuWl7rU9LcvRET/wxsKfV7ZZH9O25WcWiU8GFTy1lY5dYx2LP6KoneDMLk3uXAm4DLyiJbEzmlymmE8GnujgM+htVnPwZcBayT6M0kzNd8HXvLzqVlkf0hckqV0bfCh+OTzwE+DByLHbSwsiyyp6vORdSPsLNxT8XeA8DCssieiZtV9+kb4cNwfQr2ZpQMeBV2usytwEPqzUU7ws68ucB84IfAsrLItsXNqnv0tPBp7o7B9p9nwOnAE9jRyK4ssie7EVP0J2nujgK+iD32fRP4TllkL8fNqvP0lPBhGHYi/+3FJwJrMMl/pVcdiUMlzd2x2Iz+HOB6YEVZZC/Ezapz1F740IvPwHryWcDfCL048IiG6qIbhJ15F2GTveuAbwP39/rfW+2ED0OrqdjLCk/H1snXAWuxN5U+35U8hWhDmrsR2OTvXGxEeSvwc+DBXnxrblTh09wdCZwEnIpNuE3BatgfBO4O7clev6uK/iDN3Ths1Wc28A5sdn8NcBfwVC/8nVYifDp/1QnABOwOeSJwQmgD2Lr47/Y0nV0meoE0d4cDp2HVe2dgS7+PAg8DD4XrprqdgnTAwodzxkYDRwNjsBr01vYa7Oin8eWys8en81fdAzwNlNhM+uPA+rLI/tmZjyFEXMIN4GTgXXu1CcBW4KnQNgDPAFuAzcCWqo/qOiDh09w9C+wAtgF/B14Anh+ibQE2l8vO3hW70k6IGIRVpTHAZOD4cH09Ni81LrQjgO2YU3u82hZ+tnOItgvYDXhgd1lk1+x3Ut772jXgfMXXd6DfQefjDxzMnasCzlf86MTOIXZ8iJ9Dx+PXVXghRBeQ8EI0iLoKf73iRyd2DrHjQ/wcOh6/++vwQojaUNceXgjRBYbHTgAgSZIZWNXSc977G5MkmQ28E3jUe39H1fHDz1YAN3vvB7sdv10OSZIsBl4C7vTer48Qfzr2ZpdB7/093Y4/RA4fBN4KjPTeL4wQfy72piG891dFiH8edhTbJu/9bZ2IUZcefpr3vsCq9AAGgeOAqk4Y3Sd+kiTnAL+pKHbbHLCiplER48/Bij+qLA3dJwfv/e1YhdqPY8QHhmFFMs9Fij/Be78c2yXaEeoi/D4TCd77F4ELgUkx4gNvB96LvcKoKlp/B9dixy99KEZ8YHTI4cyK4rfLAeBt3vs/Roo/4L1fgFXIxYi/NkmSi7HKu45QiyE9MJgkyXxga5Ikp2A7kSZjPX3l8b33i5MkmUl1I4z/yQF4M7aT8N5I8VcnSXIJsKmi+O1y2IjVoseKf2SSJF/AysRjxB/ASm9/1qkAmqUXokHUZUgvhKgACS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwQjSI/wDY9GkpaFYVPQAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABZBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200microg/Formoterol 6microg/dose inh CFC free : 35</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BJABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 inhaler : 43</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BPAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 50micrograms/dose inhaler : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BPABBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 100micrograms/dose inhaler : 172</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BPACBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 200micrograms/dose inhaler : 76</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BQAABX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 100micrograms/dose / 6micrograms/dose inhaler : 90</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BQABBZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair 200micrograms/dose / 6micrograms/dose inhaler : 49</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BRAABY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 102</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BTADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Soprobec 250micrograms/dose inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BNAABU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Easyhaler Beclometasone 200micrograms/dose dry pdr inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BPADBW&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Clenil Modulite 250micrograms/dose inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABFBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100micrograms/dose inhaler CFC free : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABXBX&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BRABCA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABEBE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 50micrograms/dose inhaler CFC free : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BJADBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100 Autohaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABVBV&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 200micrograms/dose inhaler CFC free : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0AABYBY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Beclometasone 100microg/Formoterol 6microg/dose dry pdr inh : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BJAABE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 50 inhaler : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0302000C0BJAFBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Qvar 100micrograms/dose Easi-Breathe inhaler : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Theophylline</td>
      <td>28</td>
      <td>0.29</td>
      <td>0.83</td>
      <td>0.25</td>
      <td>-2.22</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301030S0BKACAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 300mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Antimuscarinic drugs</td>
      <td>11</td>
      <td>0.09</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G81031&amp;numIds=1501030G0AAAAAA&amp;denomIds=15.1.3&amp;selectedTab=summary" target="_blank">Glycopyrronium bromide 200micrograms/1ml inj ampoules : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>